title: The price of success: cost-effectiveness of molecularly targeted agents.
abstract: The advent of molecularly targeted agents has brought major breakthroughs in oncology. However, because these drugs are expensive and financial resources are limited, attention to their cost-effectiveness is rapidly increasing. It seems that establishment of cost-effectiveness is complex but is determined for the most part by the cost of drug acquisition and the drug's efficacy. This article examines the cost-effectiveness of molecularly targeted drugs.
authors.affiliation: Department of Medical Oncology, Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. s.sleijfer@erasmusmc.nl
authors.forename: S
authors.initials: S
authors.lastname: Sleijfer
authors.forename: J
authors.initials: J
authors.lastname: Verweij
mesh_terms: D000818:Animals; D003362:Cost-Benefit Analysis; D016527:Drug Costs / Q000639:trends; D016503:Drug Delivery Systems / Q000191:economics* / Q000639:trends; D006801:Humans; D004364:Pharmaceutical Preparations / Q000008:administration & dosage / Q000191:economics*
chemical_list: D004364:Pharmaceutical Preparations